Safety and tolerability of deferasirox in pediatric hematopoietic stem cell transplant recipients: one facility's five years’ experience of chelation treatment

42 pediatric patients with iron overload, who underwent liver biopsy and DFX treatment after hematopoietic stem cell transplantation were included in the study group. The patients were divided into two groups diversified according to deferasirox trough plasma concentrations (DFX C(trough)) with cut-...

Descripción completa

Detalles Bibliográficos
Autores principales: Maximova, Natalia, Gregori, Massimo, Simeone, Roberto, Sonzogni, Aurelio, Boz, Giulia, Fucile, Carmen, Marini, Valeria, Martelli, Antonietta, Mattioli, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609912/
https://www.ncbi.nlm.nih.gov/pubmed/28968980
http://dx.doi.org/10.18632/oncotarget.18725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609912/
https://www.ncbi.nlm.nih.gov/pubmed/28968980
http://dx.doi.org/10.18632/oncotarget.18725

Ejemplares similares